J. Burghouts

发表

Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study

C. Punt, D. Wagener, P. Mulder, 2004, Cancer Chemotherapy and Pharmacology.

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy.

P. Postmus, N. van Zandwijk, T. Splinter, 1987, European journal of cancer & clinical oncology.

Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.

P. Postmus, D. Carney, A. Planting, 1992, European journal of cancer.

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

G. Giaccone, P. Postmus, R. Dziadziuszko, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study.

G. Giaccone, P. Postmus, J. V. van Meerbeeck, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.

G. Giaccone, G. Scagliotti, P. Postmus, 1996, European journal of cancer.

Phase II trial of cisplatin for adenocarcinoma of unknown primary site

J. Croles, P. Mulder, J. Burghouts, 1991 .

A multicenter phase II trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer.

O. Dalesio, T. Splinter, F. ten Kate, 1986, Seminars in oncology.

Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer.

C. Punt, P. D. de Mulder, J. Burghouts, 1992, Seminars in oncology.

Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group.

G. Giaccone, O. Dalesio, H. Groen, 1997, European journal of cancer.

Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

G. Giaccone, O. Dalesio, P. Postmus, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

G. Giaccone, B. Dautzenberg, N. van Zandwijk, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.

G. Giaccone, O. Dalesio, A. Gregor, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer.

F. Erdkamp, P. Hupperets, G. Blijham, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long term survival of small cell lung cancer patients after chemotherapy.

P. Postmus, T. Splinter, A. van der Gaast, 1993, British Journal of Cancer.

Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923).

G. Giaccone, T. Gorlia, A. Ardizzoni, 2003, Annals of Oncology.

Severe copper deficiency due to excessive use of an antacid combined with pyloric stenosis

L. Engels, J. Burghouts, P. M. Kalmthout, 1982, Digestive Diseases and Sciences.

A case of AMMoL with 8/21 translocation and loss of the Y as probably secondary events

A. Smits, J. Scheres, T. Hustinx, 1980, Cancer.

Two carboplatin-containing regimens for small cell lung cancer: preliminary results of a randomized phase II trial.

O. Dalesio, P. Postmus, D. Carney, 1988, Cancer treatment reviews.

Teniposide for meningeal carcinomatosis of small cell lung cancer.

P. Postmus, H. Haaxma-Reiche, J. Burghouts, 1993, Lung cancer.

Acute toxicity of alternating schedule of chemotherapy and irradiation in limited small-cell lung cancer in a pilot study (08877) of the EORTC Lung Cancer Cooperative Group.

O. Dalesio, A. Gregor, P. Postmus, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.

J. Klijn, M. Piccart, L. Mauriac, 2000, Journal of the National Cancer Institute.

Inhibitory effect of rifampicin on rauscher‐virusinduced murine leukaemia

H. Bloemendal, J. Burghouts, A. Gielkens, 1972, International journal of cancer.

Continuous infusion of high‐dose 5‐fluorouracil in combination with leucovorin and recombinant interferon‐alpha‐2b in patients with advanced colorectal cancer. A multicenter phase II study

C. Punt, P. D. De Mulder, J. Burghouts, 1993, Cancer.

Alternating versus sequential chemoradiotherapy in Limited Small Cell Lung Cancer (SCLC). EORTC phase II trial

A. Gregor, P. Postmus, M. Rinaldi, 1991 .